Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors.
Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2025 01; 177:108834.
PMID: 39395860
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy.
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Nov 01; 31(11).
PMID: 39093924
Comparison of Measurement and Prognostic Power of SUV Between High-Definition and Standard PET Imaging in Non-Small Cell Lung Cancer Patients.
Comparison of Measurement and Prognostic Power of SUV Between High-Definition and Standard PET Imaging in Non-Small Cell Lung Cancer Patients. J Nucl Med Technol. 2024 Sep 05; 52(3):229-233.
PMID: 39019575
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL. Clin Lymphoma Myeloma Leuk. 2024 02; 24(2):83-93.
PMID: 37827881
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group.
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group. JCO Clin Cancer Inform. 2021 12; 5:1181-1188.
PMID: 34882497
Implementation of a hybrid angiography-CT system: increased short-term revenue at an academic radiology department.
Implementation of a hybrid angiography-CT system: increased short-term revenue at an academic radiology department. Abdom Radiol (NY). 2021 11; 46(11):5428-5433.
PMID: 34228198
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma. Blood. 2021 06 17; 137(24):3454-3459.
PMID: 33881502
Improved Utilization Following Conversion of a Fluoroscopy Suite to Hybrid CT/Angiography System.
Improved Utilization Following Conversion of a Fluoroscopy Suite to Hybrid CT/Angiography System. J Vasc Interv Radiol. 2020 11; 31(11):1857-1863.
PMID: 33041175
Interventional Techniques for the Ablation and Augmentation of Extraspinal Lytic Bone Metastases.
Interventional Techniques for the Ablation and Augmentation of Extraspinal Lytic Bone Metastases. Semin Intervent Radiol. 2019 Aug; 36(3):221-228.
PMID: 31435130